Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-10 09:39 am Sale |
2022-12-31 | 13G | AnaptysBio, Inc. ANAB |
Flynn James E | 1,161,826 4.090% |
-304,774 (-20.78%) |
Filing History |
| 2023-02-09 11:07 am Sale |
2022-12-30 | 13G | AnaptysBio, Inc. ANAB |
The Vanguard Group | 1,776,908 6.250% |
-65,775 (-3.57%) |
Filing History |
| 2023-02-09 10:39 am Sale |
2023-01-31 | 13G | AnaptysBio, Inc. ANAB |
FEDERATED HERMES INC. FHI |
1,401,559 4.930% |
-971,464 (-40.94%) |
Filing History |
| 2023-02-01 09:49 am Purchase |
2022-12-31 | 13G | AnaptysBio, Inc. ANAB |
FEDERATED HERMES INC. FHI |
2,373,023 8.350% |
1,053,850 (+79.89%) |
Filing History |
| 2023-01-31 5:52 pm Sale |
2022-12-31 | 13G | AnaptysBio, Inc. ANAB |
BlackRock Inc. BLK |
1,856,266 6.500% |
-9,022 (-0.48%) |
Filing History |
| 2022-09-09 4:54 pm Purchase |
2022-08-30 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 2,281,200 8.100% |
2,009,971 (+741.06%) |
Filing History |
| 2022-08-15 5:47 pm Purchase |
2022-08-11 | 13G | AnaptysBio, Inc. ANAB |
Flynn James E | 1,466,600 5.190% |
654,116 (+80.51%) |
Filing History |
| 2022-05-10 12:08 pm Sale |
2022-04-30 | 13G | AnaptysBio, Inc. ANAB |
FEDERATED HERMES INC. FHI |
1,319,173 4.680% |
-285,114 (-17.77%) |
Filing History |
| 2022-02-14 7:09 pm Sale |
2021-12-31 | 13G | AnaptysBio, Inc. ANAB |
Perceptive Advisors LLC | 0 0.000% |
-1,495,336 (Position Closed) |
Filing History |
| 2022-02-14 4:38 pm Sale |
2021-12-31 | 13G | AnaptysBio, Inc. ANAB |
Point72 Asset Management, L.P. | 271,229 1.000% |
-1,106,713 (-80.32%) |
Filing History |
| 2022-02-14 1:34 pm Purchase |
2021-12-31 | 13G | AnaptysBio, Inc. ANAB |
FEDERATED HERMES INC. FHI |
1,604,287 5.800% |
330,520 (+25.95%) |
Filing History |
| 2022-02-09 3:24 pm Sale |
2021-12-31 | 13G | AnaptysBio, Inc. ANAB |
The Vanguard Group | 1,842,683 6.670% |
-377,638 (-17.01%) |
Filing History |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | AnaptysBio, Inc. ANAB |
BlackRock Inc. BLK |
1,865,288 6.800% |
-42,546 (-2.23%) |
Filing History |
| 2021-05-11 4:08 pm Purchase |
2021-05-04 | 13D | AnaptysBio, Inc. ANAB |
EcoR1 Capital LLC | 7,520,424 27.500% |
368,800 (+5.16%) |
Filing History |
| 2021-04-12 5:45 pm Unchanged |
2021-04-08 | 13D | AnaptysBio, Inc. ANAB |
EcoR1 Capital LLC | 7,151,624 26.100% |
0 (Unchanged) |
Filing History |
| 2021-03-10 5:17 pm Purchase |
2021-03-08 | 13D | AnaptysBio, Inc. ANAB |
EcoR1 Capital LLC | 7,151,624 26.100% |
3,338,300 (+87.54%) |
Filing History |
| 2021-03-10 5:02 pm Purchase |
2021-03-08 | 13D | AnaptysBio, Inc. ANAB |
EcoR1 Capital Fund L.P. | 7,151,624 26.100% |
7,151,624 (New Position) |
Filing History |
| 2021-02-16 4:15 pm Purchase |
2020-12-31 | 13G | AnaptysBio, Inc. ANAB |
TANG CAPITAL PARTNERS LP | 2,628,678 9.600% |
784,864 (+42.57%) |
Filing History |
| 2021-02-12 07:04 am Sale |
2020-12-31 | 13G | AnaptysBio, Inc. ANAB |
STATE STREET CORP STT |
1,215,576 4.440% |
-729,433 (-37.50%) |
Filing History |
| 2021-02-11 4:41 pm Sale |
2020-12-31 | 13G | AnaptysBio, Inc. ANAB |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-1,441,565 (Position Closed) |
Filing History |